openPR Logo
Press release

Revolutionizing Workplace Safety and Accountability: Intelligent Bio (NASDAQ: INBS) Surpasses 1,000 Installations of Drug Screening Readers, Marking 65% Growth in One Year SMFL, WENA, WW

08-21-2024 11:16 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Revolutionizing Workplace Safety and Accountability:

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is transforming how companies approach this challenge with the introduction of the INBS Drug Reader, a groundbreaking tool designed to enhance workplace safety and accountability. Workplace safety is a top priority for industries where even a minor lapse in judgment or concentration can have serious consequences. In sectors such as manufacturing, construction, and logistics, ensuring that employees are fit for duty is essential. However, traditional drug testing methods often fall short, leading to delays in decision-making and potential risks to safety.

This Just In: Intelligent Bio Solutions Surpasses 1,000 Installations of Drug Screening Readers, Marking 65% Growth in One Year

NEW YORK, Aug. 21, 2024 - Intelligent Bio Solutions Inc. (NASDAQ: $INBS), a leader in non-invasive drug testing, announced the installation of over 1,000 Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024. In the fiscal year ending June 2024, the company sold 407 readers, up 26% from the previous year, bringing the total installed readers to 1,037-a 65% increase from 630 in June 2023. Read more. [https://finance.yahoo.com/news/intelligent-bio-solutions-inc-achieves-123000149.html]

The Limitations of Traditional Drug Testing

Traditional drug testing methods, including urine, saliva, and hair tests, have long been the standard in workplace safety protocols. However, these methods come with significant drawbacks. Urine tests, for example, can take 24 to 72 hours to deliver results, leaving employers in a state of uncertainty when rapid decisions are crucial. Saliva tests, while quicker, may not effectively detect long-term substance use. Hair testing, although it provides an extended detection window, can take up to 10 days to produce results, causing further delays in addressing potential safety risks.

These inefficiencies can lead to a reactive approach to workplace safety, where issues are addressed only after they have already caused harm. In industries like manufacturing, where heavy machinery is operated in close quarters, or in construction, where workers face hazardous environments daily, this delay can be costly and dangerous.

The INBS Drug Reader: A New Era of Workplace Safety

The INBS Drug Reader addresses these challenges head-on by providing a rapid, non-invasive solution for drug testing. Utilizing advanced biometric techniques, the device analyzes fingerprint sweat to detect drug use within a 16 to 24-hour window. The most significant advantage of the INBS Drug Reader is its ability to deliver results in just 10 minutes. This rapid turnaround time allows employers to make informed decisions quickly, preventing potential accidents and maintaining a safe work environment.

The device's portability and tamper-proof design make it ideal for on-site testing and random drug testing policies. Unlike traditional methods that often require off-site sample analysis and third-party involvement, the INBS Drug Reader can be easily deployed on location, ensuring that testing is both efficient and reliable.

Impact Across Critical Sectors

The transformative impact of the INBS Drug Reader is particularly evident in high-risk industries where safety and productivity are closely linked. In manufacturing, where precision and focus are critical, the ability to test employees on the spot ensures that only those who are truly fit to work are allowed on the production floor, reducing the risk of accidents and machinery-related injuries.

In the construction industry, where the stakes are even higher, ensuring that all workers are drug-free is essential for preventing workplace injuries and fatalities. The INBS Drug Reader's rapid testing capabilities help construction companies maintain stringent safety standards, protecting both workers and the integrity of their projects.

The logistics sector, particularly trucking and transportation, also stands to benefit significantly from the INBS Drug Reader. With the ability to conduct on-the-spot testing, companies can ensure that drivers are not under the influence while operating vehicles, thereby reducing the risk of road accidents and improving overall safety on the roads.

A Commitment to Safety and Accountability

Intelligent Bio Solutions Inc. is at the forefront of workplace safety innovation with the INBS Drug Reader. By addressing the limitations of traditional drug testing methods and providing a solution that meets the immediate needs of employers, INBS is setting a new standard in drug testing technology.

"The INBS Drug Reader not only enhances workplace safety by providing rapid and reliable results but also empowers employers to act swiftly, preventing accidents before they happen," said [Name, Title] of Intelligent Bio Solutions. "Our commitment to safety and accountability is reflected in this technology, which we believe will have a lasting impact across various industries."

As organizations continue to prioritize employee well-being and operational safety, the INBS Drug Reader stands out as a critical tool in the fight against workplace drug use. With its ability to deliver immediate results, enhance safety protocols, and support a culture of accountability, this innovative device is poised to revolutionize workplace safety in critical sectors.

For more information about the INBS Drug Reader and how it can help your organization maintain a safe workplace, please visit www.intelligentbiosolutions.com [http://www.intelligentbiosolutions.com/].

Here are three additional companies under $2 demonstrating robust market trends, volume, and awareness:

*
Smart for Life, Inc. (NASDAQ: SMFL): A wellness company focused on producing and distributing health and nutritional products, leveraging e-commerce and technology to expand its market reach.

*
Anew Medical, Inc. (NASDAQ: WENA): A healthcare company specializing in medical devices and health tech solutions, driving innovation in patient care and diagnostics.

*
WW International, Inc. (NASDAQ: WW): A global leader in weight management programs, incorporating digital platforms and AI-driven tools to enhance customer engagement.

These companies are actively leveraging technology in their respective sectors, showcasing market strength through their innovative products and services.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=revolutionizing-workplace-safety-and-accountability-intelligent-bio-nasdaq-inbs-surpasses-1000-installations-of-drug-screening-readers-marking-65-growth-in-one-year-smfl-wena-ww]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Revolutionizing Workplace Safety and Accountability: Intelligent Bio (NASDAQ: INBS) Surpasses 1,000 Installations of Drug Screening Readers, Marking 65% Growth in One Year SMFL, WENA, WW here

News-ID: 3630397 • Views:

More Releases from ABNewswire

Best Deals on MercyMe 2026 Tour Tickets: Get Affordable Seats at CapitalCityTickets.com with CITY10 Promo Code Today
Best Deals on MercyMe 2026 Tour Tickets: Get Affordable Seats at CapitalCityTick …
MercyMe's Wonder + Awe Tour 2026 kicks off March 12 in Greensboro, NC, featuring hits like "I Can Only Imagine" and new tracks from their upcoming album. With special guests Big Daddy Weave, Tim Timmons, and Sam Wesley, the 24+ city spring run spans the U.S., from East Coast arenas to West Coast venues, wrapping April 25 in Spokane, WA. MercyMe's Wonder + Awe Tour 2026 [https://www.capitalcitytickets.com/MercyMe-Tickets] is bringing an uplifting
Upcoming Book Offers Readers a Rare Perspective, Taking Them on a Mother's Journey from Legal Insider to Grieving Client
Upcoming Book Offers Readers a Rare Perspective, Taking Them on a Mother's Journ …
Sarah Standifird's upcoming book, Citizen's Prey, will be released on March 28 and offers a rare, unflinching look at what happens when families are forced to navigate the justice system after preventable tragedy. With years of experience in the legal industry, Sarah Standifird once worked alongside attorneys nationwide. Now, she writes from the other side of the courtroom-as a grieving mother navigating the system as a client-offering a rare and unflinching
Peak Grounding Sets New Industry Standard with Filtration Technology That Eliminates Earthing Side Effects
Peak Grounding Sets New Industry Standard with Filtration Technology That Elimin …
"We asked ourselves why the wellness industry was accepting a 43% side effect rate as normal when other health categories would find that statistic completely unacceptable. Our filters represent a fundamental reimagining of what grounding products should deliver: pure benefits without compromise, allowing users to earth confidently and comfortably." The grounding and earthing movement has captured the attention of wellness enthusiasts worldwide, driven by compelling research suggesting that direct connection with
Top Fintech Software Development Companies In France
Top Fintech Software Development Companies In France
France has become a booming center for financial technology innovation in the last several years. The country has attracted both local and worldwide technology experts who offer top-notch fintech software development services. This is because it has a strong digital infrastructure, more money is being put into fintech firms, and the government is doing things to help. If you want to develop safe, scalable, and compliant fintech solutions, you need

All 5 Releases


More Releases for INBS

"Stocks to Watch Showing Strong Market Potential INBS, NANO.T, MLGO, KAVL, PNPN. …
As investors seek opportunities in a dynamic market, several key stocks-Intelligent Bio Solutions, Nano One, Power Nickel, MicroAlgo, and Kaival Brands-are demonstrating significant growth potential driven by strategic initiatives and sector innovations. Intelligent Bio Solutions (NASDAQ: INBS): INBS has announced a 64% YoY increase in preliminary Q4 revenue and is trading up on heavy volume, reaching $3 in early trading. The stock is challenging its 200-day moving average of $2.93, and
"Game-Changing Biotech Companies Making Waves: INBS, PMVP, TPST, OMGA, MRSN"
In the rapidly evolving biotech sector, a few standout companies are pushing boundaries and setting new standards. From Intelligent Bio Solutions' innovative drug testing technology to PMV Pharmaceuticals' promising clinical trial advancements, these trailblazers are not just making headlines-they're shaping the future of healthcare while improving the workplace. Discover how these five companies are leading the charge in innovation, with significant developments that could impact industries and lives worldwide. Intelligent Bio
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
Investors frequently search for stocks of companies with improving operational performance. This article offers an in-depth look at five companies that have recently made significant progress. NKGen Biotech Inc. (NASDAQ: NKGN): A clinical-stage biotech firm, NKGen Biotech is focused on developing and commercializing allogeneic, autologous, and CAR-NK natural killer cell therapies. On May 20, the company announced that its cryopreserved autologous, enhanced, and expanded SNK01 had received clearance from the Safety
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Research Report Update May 2024
Intelligent Bio Solutions Inc. (NASDAQ: INBS) remains on track to enter the U.S. market in 2025. Sales momentum at Intelligent Bio Solutions remained strong, with the addition of 26 new accounts in the first fiscal quarter. These new accounts included 16,779 employees. Another key aspect is that Intelligent Bio Solutions continues to enhance its intellectual property portfolio. Recently, its DSR-PLUS Cartridge Reader received a European patent for unitary use. See
Market Movers on The Street: LAZR, INBS, REBN, PSRO
Luminar Technologies (NASDAQ: LAZR) The company, which manufactures lidar sensors meant for self-driving cars, was in focus on May 8 following a key announcement. Luminar Technologies revealed that in the first fiscal quarter, Tesla was its biggest customer and made up 10% of its revenues of $21 million for the quarter. It was a significant announcement since Tesla Chief Executive Officer Elon Musk is fully committed to the success of
Discovering Undervalued Stocks in Today's Market: OCGN, INBS, KAVL, DYAI, VTAK
Ocugen Inc (NASDAQ:OCGN) stock has been moving higher over the past week. This morning, the company announced that Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant Professor at the University of Arizona, College of Medicine-Phoenix will present data from the OCU400 Phase 1/2 clinical trial at the Retinal Cell and Gene Therapy Innovation Summit being held May 3, 2024 in Seattle, WA. Intelligent Bio